What You Should Know:
– Finnish health tech company Medixine has strengthened its presence in the U.S. market, announcing a deepened technological partnership with Nonin Medical, a leading manufacturer of wearable and noninvasive medical monitoring devices.
– With the U.S. market for remote patient monitoring expected to exceed USD 25 billion by 2028, the collaboration is an important milestone in Medixine’s continued U.S. growth.
Driving Healthcare Innovation: Integrating Remote Patient Monitoring and Device Technology
An aging population and cost pressures are driving digitalization in healthcare. Remote patient monitoring is increasingly used for chronic diseases, which constitute 86% of healthcare costs in the US and globally. This trend is expected to continue.
A new partnership merges Medixine’s remote patient monitoring software with Nonin’s pulse oximetry devices, aiming to enhance patient care and reduce clinician burden. The collaboration focuses on overnight oximetry for pre-screening patients for supplemental oxygen and potential sleep disorders like obstructive sleep apnea.
